{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:11:35Z","timestamp":1790946695176,"version":"4.1.0"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"5","funder":[{"DOI":"10.13039\/100012443","name":"Maryland Stem Cell Research Fund","doi-asserted-by":"publisher","award":["2009-MSCRFII-0082-00"],"award-info":[{"award-number":["2009-MSCRFII-0082-00"]}],"id":[{"id":"10.13039\/100012443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 GM064625"],"award-info":[{"award-number":["R01 GM064625"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/hmg\/ddx442","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T20:10:21Z","timestamp":1514578221000},"page":"811-822","source":"Crossref","is-referenced-by-count":48,"title":["Gaucher disease iPSC-derived osteoblasts have developmental and lysosomal defects that impair bone matrix deposition"],"prefix":"10.1093","volume":"27","author":[{"given":"Leelamma M","family":"Panicker","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasa P","family":"Srikanth","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Castro-Gomes","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Molecular Genetics, University of Maryland College Park, MD 20742, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma W","family":"Andrews","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Molecular Genetics, University of Maryland College Park, MD 20742, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"key\n\t\t\t\t20180328182237_ddx442-B1","first-page":"3635","volume-title":"The Metabolic and Molecular Bases of Inherited Disease"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B2","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.85.7.2349","article-title":"Genetic heterogeneity in type 1 gaucher disease: multiple genotypes in ashkenazic and non-ashkenazic individuals","volume":"85","author":"Tsuji","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B3","first-page":"299","article-title":"Gaucher disease: clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B5","first-page":"273","article-title":"Gaucher disease: insights from a rare Mendelian disorder","volume":"14","author":"Sidransky","year":"2012","journal-title":"Discov. Med"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B6","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/stem.1732","article-title":"Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development","volume":"32","author":"Panicker","year":"2014","journal-title":"Stem Cells"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B7","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/B978-0-444-59565-2.00040-X","article-title":"Gaucher disease","volume":"113","author":"Mignot","year":"2013","journal-title":"Handb. Clin. Neurol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/978-1-4419-6741-1_11","article-title":"Glucosylceramide in humans","volume":"688","author":"Messner","year":"2010","journal-title":"Adv. Exp. Med. Biol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10545-010-9241-0","article-title":"Gaucher disease with foamy transformed macrophages and erythrophagocytic activity","volume":"34","author":"Machaczka","year":"2011","journal-title":"J. Inherit. Metab. Dis"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"3 gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Bailli\u00e8re\u2019s Clin. Haematol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000440865","article-title":"Gaucher disease: clinical, biological and therapeutic aspects","volume":"83","author":"Dandana","year":"2016","journal-title":"Pathobiology"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides. ii. evidence of an enzymatic deficiency in gaucher's disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bjh.12804","article-title":"Gaucher disease: haematological presentations and complications","volume":"165","author":"Thomas","year":"2014","journal-title":"Br. J. Haematol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-7091-1511-4_20","article-title":"Neuronal forms of gaucher disease","volume":"216","author":"Vitner","year":"2013","journal-title":"Handb. Exp. Pharmacol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol. Genet. Metab"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B16","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","article-title":"Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic gaucher disease","volume":"20","author":"Farfel-Becker","year":"2011","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B18","doi-asserted-by":"crossref","first-page":"18054","DOI":"10.1073\/pnas.1207889109","article-title":"Induced pluripotent stem cell model recapitulates pathologic hallmarks of gaucher disease","volume":"109","author":"Panicker","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.5966\/sctm.2014-0213","article-title":"Gaucher disease-induced pluripotent stem cells display decreased erythroid potential and aberrant myelopoiesis","volume":"4","author":"Sgambato","year":"2015","journal-title":"Stem Cells Transl. Med"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B20","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1093\/hmg\/ddv297","article-title":"Altered TFEB-mediated lysosomal biogenesis in gaucher disease iPSC-derived neuronal cells","volume":"24","author":"Awad","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B21","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.stemcr.2017.10.029","article-title":"Altered differentiation potential of gaucher's disease iPSC neuronal progenitors due to wnt\/beta-catenin downregulation","volume":"9","author":"Awad","year":"2017","journal-title":"Stem Cell. Rep"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B22","doi-asserted-by":"crossref","first-page":"A37","DOI":"10.1259\/bjr.75.suppl_1.750037","article-title":"Bone complications in children with gaucher disease","volume":"75","author":"Bembi","year":"2002","journal-title":"Br. J. Radiol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0950-3536(97)80041-8","article-title":"Skeletal involvement in gaucher's disease","volume":"10","author":"Elstein","year":"1997","journal-title":"Baillieres Clin. Haematol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4081\/hr.2012.e21","article-title":"Bone turnover markers in patients with type 1 gaucher disease","volume":"4","author":"Giuffrida","year":"2012","journal-title":"Hematol. Rep"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ymgme.2011.08.004","article-title":"Therapeutic approaches to bone pathology in gaucher disease: past, present and future","volume":"104","author":"Goker-Alpan","year":"2011","journal-title":"Mol. Genet. Metab"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bcmd.2016.10.008","article-title":"Management goals for type 1 gaucher disease: an expert consensus document from the European working group on gaucher disease","volume":"68","author":"Biegstraaten","year":"2016","journal-title":"Blood Cells Mol. Dis"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases","volume":"57","author":"Brady","year":"2006","journal-title":"Annu. Rev. Med"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcmd.2011.04.005","article-title":"Significant and continuous improvement in bone mineral density among type 1 gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction","volume":"47","author":"Elstein","year":"2011","journal-title":"Blood Cells Mol. Dis"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcmd.2010.10.011","article-title":"Osteopenia in gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults","volume":"46","author":"Mistry","year":"2011","journal-title":"Blood Cells Mol. Dis"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B30","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B31","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/hmg\/ddu538","article-title":"Glucocerebrosidase deficiency in zebrafish affects primary bone ossification through increased oxidative stress and reduced wnt\/beta-catenin signaling","volume":"24","author":"Zancan","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B33","first-page":"205","article-title":"Cytokines in gaucher's disease","volume":"10","author":"Barak","year":"1999","journal-title":"Eur. Cytokine Netw"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B34","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/stem.2625","article-title":"Concise review: stem cells in osteoimmunology","volume":"35","author":"Fierro","year":"2017","journal-title":"Stem Cells"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3346\/jkms.2006.21.4.733","article-title":"Upregulation of proinflammatory cytokines in the fetal brain of the gaucher mouse","volume":"21","author":"Hong","year":"2006","journal-title":"J. Korean Med. Sci"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B36","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B37","doi-asserted-by":"crossref","first-page":"192761","DOI":"10.1155\/2015\/192761","article-title":"Pathogenesis of bone alterations in gaucher disease: the role of immune system","volume":"2015","author":"Mucci","year":"2015","journal-title":"J. Immunol. Res"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gene.2013.09.072","article-title":"Uncoupling of osteoblast\u2013osteoclast regulation in a chemical murine model of gaucher disease","volume":"532","author":"Mucci","year":"2013","journal-title":"Gene"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B40","doi-asserted-by":"crossref","first-page":"31171","DOI":"10.1074\/jbc.M102788200","article-title":"Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization","volume":"276","author":"Mornet","year":"2001","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12291-013-0408-y","article-title":"Alkaline phosphatase: an overview","volume":"29","author":"Sharma","year":"2014","journal-title":"Indian J. Clin. Biochem"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1272\/jnms.77.4","article-title":"The mechanism of mineralization and the role of alkaline phosphatase in health and disease","volume":"77","author":"Orimo","year":"2010","journal-title":"J. Nippon Med. Sch"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B43","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2741\/4026","article-title":"Acidic bone matrix proteins and their roles in calcification","volume":"17","author":"Fujisawa","year":"2012","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B44","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/s00198-002-1342-7","article-title":"Bone matrix proteins: their function, regulation, and relationship to osteoporosis","volume":"14","author":"Young","year":"2003","journal-title":"Osteoporos. Int"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1138\/20070255","article-title":"Wnt signaling in bone","volume":"4","author":"Bodine","year":"2007","journal-title":"IBMS BoneKEy"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B47","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2004.06.044","article-title":"Wnt signaling in osteoblasts and bone diseases","volume":"341","author":"Westendorf","year":"2004","journal-title":"Gene"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B49","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J. Cell. Sci"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/dvdy.22019","article-title":"Regulation of wnt\/beta-catenin signaling by protein kinases","volume":"239","author":"Verheyen","year":"2010","journal-title":"Dev. Dyn"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B52","doi-asserted-by":"crossref","first-page":"19678","DOI":"10.1074\/jbc.M802517200","article-title":"Lysosome dispersion in osteoblasts accommodates enhanced collagen production during differentiation","volume":"283","author":"Nabavi","year":"2008","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ceca.2005.06.012","article-title":"Calcium-dependent regulation of exocytosis","volume":"38","author":"Barclay","year":"2005","journal-title":"Cell Calcium"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B54","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1600-0854.2012.01395.x","article-title":"Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases","volume":"13","author":"Zhao","year":"2012","journal-title":"Traffic"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B55","doi-asserted-by":"crossref","first-page":"e0152583","DOI":"10.1371\/journal.pone.0152583","article-title":"Plasma membrane repair is regulated extracellularly by proteases released from lysosomes","volume":"11","author":"Castro-Gomes","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1083\/jcb.200205110","article-title":"Lysosomes and the plasma membrane: trypanosomes reveal a secret relationship","volume":"158","author":"Andrews","year":"2002","journal-title":"J. Cell Biol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B57","doi-asserted-by":"crossref","first-page":"16795","DOI":"10.1073\/pnas.0405905101","article-title":"Defective lysosomal exocytosis and plasma membrane repair in Chediak\u2013Higashi\/beige cells","volume":"101","author":"Huynh","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(01)00421-4","article-title":"Plasma membrane repair is mediated by Ca2+-regulated exocytosis of lysosomes","volume":"106","author":"Reddy","year":"2001","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B59","doi-asserted-by":"crossref","first-page":"26761","DOI":"10.1038\/srep26761","article-title":"Human iPSC-derived osteoblasts and osteoclasts together promote bone regeneration in 3D biomaterials","volume":"6","author":"Jeon","year":"2016","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B60","doi-asserted-by":"crossref","DOI":"10.1038\/bonekey.2013.215","article-title":"Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit","volume":"3","author":"Sims","year":"2014","journal-title":"Bonekey Rep"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4419-1050-9_5","article-title":"Regulation of osteoblast differentiation by Runx2","volume":"658","author":"Komori","year":"2010","journal-title":"Adv. Exp. Med. Biol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1750-1172-8-140","article-title":"Unfolded protein response in gaucher disease: from human to drosophila","volume":"8","author":"Maor","year":"2013","journal-title":"Orphanet J. Rare Dis"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B63","doi-asserted-by":"crossref","first-page":"e69147","DOI":"10.1371\/journal.pone.0069147","article-title":"Expression of human gaucher disease gene GBA generates neurodevelopmental defects and ER stress in drosophila eye","volume":"8","author":"Suzuki","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B64","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B65","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.26562","article-title":"Lysosomal dysfunction and alpha-synuclein aggregation in Parkinson\u2019s disease: diagnostic links","volume":"31","author":"Moors","year":"2016","journal-title":"Mov. Disord"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B66","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1080\/15548627.2015.1086055","article-title":"GBA deficiency promotes SNCA\/alpha-synuclein accumulation through autophagic inhibition by inactivated PPP2A","volume":"11","author":"Du","year":"2015","journal-title":"Autophagy"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B67","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5028","article-title":"iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis","volume":"5","author":"Schondorf","year":"2014","journal-title":"Nat. Commun"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B68","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/auto.6.5.12047","article-title":"Impaired autophagosomes and lysosomes in neuronopathic gaucher disease","volume":"6","author":"Sun","year":"2010","journal-title":"Autophagy"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B70","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1432-1033.1996.00344.x","article-title":"Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. predominant uptake by liver endothelial cells","volume":"237","author":"Bijsterbosch","year":"1996","journal-title":"Eur. J. Biochem"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2016.01.015","article-title":"A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: design, production, and assessment","volume":"221","author":"Gramlich","year":"2016","journal-title":"J. Biotechnol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B72","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1248\/bpb.31.1691","article-title":"Uptake of a recombinant human alpha-l-iduronidase (laronidase) by cultured fibroblasts and osteoblasts","volume":"31","author":"Tsukimura","year":"2008","journal-title":"Biol. Pharm. Bull"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B73","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/glycob\/cwm008","article-title":"Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of gaucher disease","volume":"17","author":"Van Patten","year":"2007","journal-title":"Glycobiology"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B74","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00256-014-1891-9","article-title":"Skeletal improvement in patients with gaucher disease type 1: a phase 2 trial of oral eliglustat","volume":"43","author":"Kamath","year":"2014","journal-title":"Skeletal Radiol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B75","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2010-03-273151","article-title":"A phase 2 study of eliglustat tartrate (genz-112638), an oral substrate reduction therapy for gaucher disease type 1","volume":"116","author":"Lukina","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B76","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jama.2015.459","article-title":"Effect of oral eliglustat on splenomegaly in patients with gaucher disease type 1: the ENGAGE randomized clinical trial","volume":"313","author":"Mistry","year":"2015","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B77","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/ajh.24877","article-title":"Outcomes after 18 months of eliglustat therapy in treatment-naive adults with gaucher disease type 1: the phase 3 ENGAGE trial","volume":"92","author":"Mistry","year":"2017","journal-title":"Am. J. Hematol"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B78","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","article-title":"Can we safely target the WNT pathway?","volume":"13","author":"Kahn","year":"2014","journal-title":"Nat. Rev. Drug Discov"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B79","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrd.2016.132","article-title":"Two pioneering osteoporosis drugs finally approach approval","volume":"15","author":"Garber","year":"2016","journal-title":"Nat. Rev. Drug Discov"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bone.2017.07.005","article-title":"Romosozumab increases bone mineral density in postmenopausal japanese women with osteoporosis: a phase 2 study","volume":"103","author":"Ishibashi","year":"2017","journal-title":"Bone"},{"key":"key\n\t\t\t\t20180328182237_ddx442-B81","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-17-0920","article-title":"Management of endocrine disease: novel anabolic treatments for osteoporosis","volume":"178","author":"Canalis","year":"2018","journal-title":"Eur. J. Endocrinol"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/27\/5\/811\/24044256\/ddx442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T05:52:09Z","timestamp":1719726729000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/27\/5\/811\/4782495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":81,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,1,2]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddx442","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3,1]]},"published":{"date-parts":[[2018,1,2]]}}}